Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...
The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$ ...
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.
EP catheters were placed in the morphologic right ... energy using a 4-mm tipped cryoablation catheter (Cryocath, Medtronic Inc., Minneapolis, MN, USA). Cryoablation at this site during AVNRT ...
From April 2007 to April 2011, a total of 334 patients who had undergone catheter ablation for sustained VT at 38 electrophysiology centers in ... A.R. received consultant fees from Medtronic, ...
Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
This comprehensive research combines qualitative and quantitative data from primary and secondary sources. It aims to provide an in-depth understanding of the current market scenario and the impact of ...